CLASS II ONGOING Device recall · Reported 26 Nov 2025 · FDA Enforcement Report

ReQuest Measles IgG Rubeola IgG Enzyme Linked Immunoabsorbant Assay recalled

Quest International is recalling ReQuest Measles IgG Rubeola IgG Enzyme Linked Immunoabsorbant Assay, distributed in Utah, Washington. The recall was initiated on 1 Oct 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Code: DI# 00850487007357 Lots affected: L07024 and E03025

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0534-2026
FDA event ID
97763
Recalling firm
Quest International, Doral, FL
Classification
Class II
Status
Ongoing
Recall initiated
1 Oct 2025
FDA classified
17 Nov 2025
Reported
26 Nov 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

1 Oct 2025Recall initiated by company
17 Nov 2025Classified by FDA+47 days
26 Nov 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to distributing the measles IgG IVD without a premarket approved/cleared.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Brand Name: ReQuest Measles IgG Product Name: Rubeola IgG Enzyme Linked Immunoabsorbant Assay Model/Catalog Number: 01-190 Software Version: N/A Product Description: Measles IgG tests, performed using ELISA (Enzyme-Linked Immunosorbent Assay) method, used to detect the presence of IgG antibodies against measles virus in a patient's serum or plasma Component: not a component

Where it was distributed

All products were distributed in the United States. (Utah, Washington).

UtahWashington

Questions about this recall

Is ReQuest Measles IgG Rubeola IgG Enzyme Linked Immunoabsorbant Assay recalled?

Yes. Quest International recalled ReQuest Measles IgG Rubeola IgG Enzyme Linked Immunoabsorbant Assay on 1 Oct 2025. The recall is Class II and its status is Ongoing. Recall number Z-0534-2026.

Why was it recalled?

Due to distributing the measles IgG IVD without a premarket approved/cleared.

Which lots are affected?

Lot Code: DI# 00850487007357 Lots affected: L07024 and E03025

Where was it sold?

All products were distributed in the United States. (Utah, Washington).

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Quest International

All 2

Other Test Kits & Diagnostics recalls

All 2,656